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Abstract
Aims/hypothesis Most genetic variants identified for type 2
diabetes have been discovered in European populations. We
performed genome-wide association studies (GWAS) in a
Chinese population with the aim of identifying novel vari-
ants for type 2 diabetes in Asians.
Methods We performed a meta-analysis of three GWAS
comprising 684 patients with type 2 diabetes and 955 con-
trols of Southern Han Chinese descent. We followed up the
top signals in two independent Southern Han Chinese co-
horts (totalling 10,383 cases and 6,974 controls), and
performed in silico replication in multiple populations.
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Results We identified CDKN2A/B and four novel type 2
diabetes association signals with p<1×10−5 from the meta-
analysis. Thirteen variants within these four loci were
followed up in two independent Chinese cohorts, and
rs10229583 at 7q32 was found to be associated with type 2
diabetes in a combined analysis of 11,067 cases and 7,929
controls (pmeta=2.6×10
−8; OR [95% CI] 1.18 [1.11, 1.25]). In
silico replication revealed consistent associations across mul-
tiethnic groups, including five East Asian populations (pmeta=
2.3×10−10) and a population of European descent (p=8.6×
10−3). The rs10229583 risk variant was associated with ele-
vated fasting plasma glucose, impaired beta cell function in
controls, and an earlier age at diagnosis for the cases. The
novel variant lies within an islet-selective cluster of open
regulatory elements. There was significant heterogeneity of
effect between Han Chinese and individuals of European
descent, Malaysians and Indians.
Conclusions/interpretation Our study identifies rs10229583
near PAX4 as a novel locus for type 2 diabetes in Chinese
and other populations and provides new insights into the
pathogenesis of type 2 diabetes.
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Introduction
Type 2 diabetes is a common complex disease characterised
by deficient insulin secretion and decreased insulin sensitivity.
In 2010, 285 million people worldwide were affected by type
2 diabetes [1], with 60% of them located in Asia [2, 3]. China
now has the largest number of patients with diabetes in the
world, with an estimated 92 million affected individuals, and
an additional 150 million with impaired glucose tolerance [4].
To identify common type 2 diabetes susceptibility vari-
ants, large-scale genome-wide association studies (GWAS)
have been conducted in white individuals, yielding more
than 60 genetic loci to date [5, 6]. Although many of these
regions have been successfully replicated in Asian
populations [7–11], discrepancies in allelic frequencies and
effect sizes have demonstrated that interethnic differences
exist. GWAS conducted in Japanese individuals [12, 13], as
well as meta-analyses of GWAS in South Asian [14] and
East Asian [15] groups, have revealed additional variants
not detected in GWAS with white individuals, with several
signals, including KCNQ1, later replicated in many
populations [12, 13]. Previous GWAS in Chinese suggested
several loci but lacked large-scale replication [16–18].
We therefore conducted this study to identify new type 2
diabetes susceptibility loci in Southern Han Chinese individ-
uals. We performed a meta-analysis of three GWAS compris-
ing 684 patients with type 2 diabetes and 955 controls, and
analysed 2.9 million (genotyped and imputed) single-
nucleotide polymorphisms (SNPs) in an additive model. Pu-
tatively associated SNPs (p<1×10−5) were genotyped de
novo in two independent Southern Han Chinese cohorts
(10,383 cases and 6,974 controls), and SNPs reaching a
genome-wide significance of p<5×10−8 were replicated in
silico in five East Asian and three non-East Asian populations
for a total of 31,541 cases and 60,344 controls.
Methods
Participants In the first-stage discovery cohort (stage 1), we
performed genome-wide scanning in three different case–
control samples: 198 Hong Kong Chinese individuals (99
patients with type 2 diabetes and 99 healthy controls) in
Hong Kong GWAS 1, 1,047 Hong Kong Chinese individ-
uals (388 with type 2 diabetes and 659 controls) in Hong
Kong GWAS 2 and 394 Shanghai Chinese (197 patients
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with type 2 diabetes and 197 normal controls) in the Shang-
hai GWAS. Individuals included in the stage 2 replication
included 5,366 with type 2 diabetes and 2,474 controls from
Hong Kong, and 4,035 cases and 3,964 controls from
Shanghai. We also included 325 cases and 368 controls
from 178 Hong Kong families, as well as 657 cases and
168 controls from 248 Shanghai families.
Case–control samples for in silico replication in stage 3
were taken from several published type 2 diabetes GWAS in
East Asian individuals. These included the Korea Associa-
tion Resource Study [19], the Singapore Chinese from the
Singapore Diabetes Cohort Study and the Singapore Pro-
spective Study Program [20], the BioBank Japan Study [13]
and a Han Chinese Study [21]. For stage 4 in silico replica-
tion in other populations, Malaysian participants from the
Singapore Malay Eye Study, Indian participants from the
Singapore Indian Eye Study [20] and participants of Euro-
pean descent in the Diabetes Genetics Replication And
Meta-analysis (DIAGRAM) Consortium [6] were included.
The study design, type 2 diabetes diagnostic criteria and
clinical evaluation used in each study are described in the
electronic supplementary material (ESM) Methods. The
clinical characteristics of the study individuals are described
in Table 1. Each study obtained approval from the appro-
priate institutional review boards of the respective institu-
tions, and written informed consent was obtained from all
participants. The overall study design is depicted in Fig. 1.
Quality control on the samples for the GWAS In our study,
individuals were excluded from further analysis if: (1) dupli-
cate samples existed; (2) the sex identified from the X chro-
mosome was discordant with the sex obtained from the
medical records; (3) the genotype call rate yield was <98%.
We detected possible familial relationship using estimates of
identity by descent derived from pair-wise analyses of inde-
pendence (r2≈0) and quality SNPs. Individuals with evidence
for relatedness were excluded ( bp1 > 0:05 ). ESM Table 1
shows the quality control for the participants in stage 1.
To discriminate individuals from different geographical
origins, we conducted multidimensional scaling analysis
using the genotype data obtained from unrelated individuals
in the present study and the other 11 populations stud-
ied by the HapMap project (ESM Fig. 1). Individuals
were excluded from subsequent analyses if they lay between
clusters.
Genotyping and quality control on the SNP data Individuals
for the stage 1, 3 and 4 analyses were genotyped using high-
density SNP typing arrays that covered the entire genome.
Only autosomal SNPs were included. Quality checks for
SNPs were performed in the case and control samples sep-
arately, although the same criteria were applied to each.
SNPs were excluded from further analysis if: (1) p<1×
10−4 for Hardy–Weinberg equilibrium (HWE); (2) minor
allele frequency (MAF) was <1%; (3) call rate was <95%;
in particular, SNPs with MAF≥1% but ≤5% were excluded
if their call rate was <99%; or (4) the SNPs showed a
significant difference in MAF (p<1×10−4) between the
Hong Kong control cohorts with other conditions (450 with
epilepsy, 110 with eczema and 99 non-hypertensive individ-
uals). Only SNPs that passed the quality control criteria for
both cases and controls were used for further analysis. ESM
Table 2 shows the quality control of the genotyping results
in stage 1. We imputed genotypes for autosomal SNPs
according to the 1000 Genomes reference panel. See the
ESM Methods for further details.
For de novo replication in stage 2, all selected SNPs were
genotyped in the Hong Kong and Shanghai case–control
samples by a primer extension of multiplex products with
detection by Matrix-assisted laser desorption ionisation-time
of flight mass spectroscopy using a MassARRAY platform
(Sequenom; San Diego, CA, USA). Family samples were
genotyped using TaqMan SNP Genotyping Assays (Applied
Biosystems, Foster City, CA, USA) or by direct sequencing.
Statistical analysis All statistical analyses were performed
using PLINK version 1.07 (http://pngu.mgh.harvard.
edu/~purcell/plink/) [22], SAS version 9.1 (SAS Institute,
Cary, NC, USA) or SPSS for Windows version 18 (SPSS,
Chicago, IL, USA), unless specified otherwise. Haploview
version 4.1 was used to generate pair-wise linkage disequi-
librium (LD) measures (r2).
To test for an association with type 2 diabetes, we applied
logistic regression under an additive genetic model using the
MACH2DAT software (www.sph.umich.edu/csg/abecasis/
MACH/download/) [23] adjusted for sex and age according
to situations in the individual studies.
To combine the type 2 diabetes association results in
stage 1, GWAMA software (www.well.ox.ac.uk/gwama/)
[24] was used to calculate the combined estimates of the
ORs (95% CIs) from multiple groups by weighting the
natural log-transformed ORs of each study using the inverse
of their variance under the random effect model [25]. By
using the random effect model, we excluded SNPs with
some degree of heterogeneity between studies, which helped
to attenuate the number of false-positive findings in this
study. Cochran’s Q statistic (p<0.05) and I2 index were used
to assess the heterogeneity of ORs between studies.
The most strongly associated SNPs were prioritised for
follow-up in stage 2 based on the meta-analysis results from
stage 1. SNPs located within a previously reported type 2
diabetes locus were excluded. We finally considered 13 top
and proxy SNPs from four distinct loci available in all three
GWAS with (1) a meta-analysis p<1×10−5; (2) a heteroge-
neity test p>0.05; (3) the same direction of risk allele across
all three GWAS; (4) a common allele frequency (MAF≥0.1).
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For SNPs imputed across all three studies, we selected the
most significant SNP associated with type 2 diabetes. ESM
Tables 3 and 4 describe the details of the selected SNPs and
the quality control for the genotyping results in stage 2.
In the replication stage, genotype frequencies were com-
pared between cases and controls using logistic regression
under an additive genetic model. In the family studies,
alternating logistic regressions (ALR) implemented in the
SAS procedure GENMOD was used to test for the associa-
tion between type 2 diabetes and SNPs under an additive
genetic model adjusted for age and sex. ALR is one type of
generalised estimating equation applicable to binary out-
comes that can handle correlated data (e.g. familial correla-
tion). ORs (95% CIs) are presented in both analyses. Meta-
Table 1 Clinical characteristics of the participants
Study Cohort N (male %) Age (years) AAD (year) Diabetes duration (years) BMI (kg/m2) FPG (mmol/l)
Stage 1 (genome scan)
HK1 Control 99 (36.4) 37.3±10.2 – – 20.8±2.0 4.7±0.4
T2D patient 99 (40.4) 40.6±8.8 31.8±7.7 8.0±8.3 30.9±4.4 –
HK2 Diseased control 659 (48.7) 37.1±17.0 – – 23.3±3.7 –
T2D patient 388 (49.5) 60.6±10.8 51.1±12.1 9.5±7.0 25.0±3.8 –
SH Control 197 (50.8) 66.4±10.1 – – 20.6±1.7 4.8±0.4
T2D patient 197 (57.9) 41.6±10.4 34.5±4.8 7.3±8.5 23.8±4.1 –
Stage 2 (de novo replication in Chinese)
HK1 Adolescent control 985 (44.2) 15.5±1.9 – – 22.7±5.4 4.9±0.4
Adults control 513 (47.0) 42.0±10.4 – – 19.9±3.5 4.7±0.3
Elderly control 976 (51.4) 72.3±5.3 – – 23.2±3.2 –
T2D patient 5,366 (45.1) 56.7±13.4 48.8±14.9 6.6±6.9 24.6±5.3 –
SH1 Control 3,964 (37.6) 51.3±13.5 – – 23.6±3.2 5.0±0.5
T2D patient 4,035 (52.0) 61.2±12.1 54.2±11.3 7.2±6.9 24.5±3.5 –
HK Family 2 Control 368 (41.0) 37.0±13.6 – – 24.0±4.1 4.9±0.4
T2D patient 325 (40.6) 48.0±14.4 41.7±13.1 6.3±7.6 25.9±4.4 –
SH Family 2 Control 168 (51.2) 62.8±11.2 – – 23.7±3.5 4.8±0.6
T2D patient 657 (43.7) 54.6±15.6 50.0±14.2 4.9±7.3 23.9±3.5 –
Stage 3 (in silico replication in East Asians)
Japanese Control 3,023 (54.5) 51.9±15.2 – – 22.4±3.7 –
T2D patient 4,465 (68.0) 65.8±10.0 56.5±11.4 9.4±8.4 24.1±3.8 –
Korean 1 Control 2,943 (46.0) 51.1±8.6 – – 24.1±3.0 4.5+0.4
T2D patient 1,042 (51.7) 56.4±8.6 – – 25.5±3.3 7.0±2.6
Korean 2 Control 1,305 (54.5) 65.2±2.6 – – 23.9±3.0 5.0±0.5
T2D patient 1,183 (46.5) 58.6±7.1 – – 25.2±3.4 7.4±2.7
Singapore Chinese 1 Control 1,006 (21.6) 47.7±11.1 – – 22.3±3.7 4.7±0.4
T2D patient 1,082 (37.2) 65.1±9.7 55.7±12.0 – 25.3±3.9 –
Singapore Chinese 2 Control 939 (63.8) 46.7±10.2 – – 22.8±3.4 4.7±0.5
T2D patient 928 (64.9) 63.7±10.8 52.2±14.4 – 25.4±3.8 –
Chinese Control 1,839 (43.7) 54.1±9.2 – – 24.00±3.18 5.04±0.35
T2D patient 1,873 (46.0) 58.6±8.4 – – 25.00±3.24 8.43±2.90
Stage 4 (in silico replication in non-East Asians)
Singapore Malaysian Control 1,240 (52.0) 56.9±11.4 – – 25.1±4.8 –
T2D patient 794 (51.0) 62.3±9.90 54.4±11.2 – 27.8±4.9 –
Singapore Indians Control 1,169 (48.4) 55.7±9.7 – – 25.3±4.4 –
T2D patient 977 (54.4) 60.7±9.9 51.4±10.6 – 27.1±5.1 –
DIAGRAM+ Control 38,987 (–) – – – – –
T2D patient 8,130 (–) – – – – –
Data are shown as N, percentage or mean ± SD
T2D, type 2 diabetes
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analyses and heterogeneity tests were conducted as described
previously to combine estimates of the ORs (95% CIs) from
multiple case–control and family groups under the fixed effect
model. Multiple testing in the combined analysis of the case–
control study were controlled by Bonferroni correction, and p
<4.5×10−3 (0.05 divided by 11 SNPs in the stage 2 replication
studies) was used as the threshold for filtering SNPs geno-
typed in the family studies.
Continuous data are presented as mean ± SD or geomet-
ric mean (95% CI). Traits were loge-transformed due to
skewed distributions. Associations between genotypes and
quantitative traits were tested by linear regression (adjusted
for sex, age and/or BMI) in each healthy control cohort, as
were associations for age at diagnosis (AAD) among pa-
tients with type 2 diabetes (adjusted for sex, BMI and/or
HbA1c). Meta-analyses implemented by GWAMA were
CDKN2A/B + 11 top and proxy SNPs in four loci
P<1×10-5
Stage 1: meta-analysis of three GWAS in the Chinese population
Hong Kong GWAS 1
using Illumina 550K chip
(99 cases and 99 controls)
Hong Kong GWAS 2
using Illumina 610K chip
(388 cases and 659 controls)
Shanghai GWAS
using Illumina 370K chip
(197 cases and 197 controls)
Imputation using the haplotypes of CHB + JPT in
the 1,000 Genomes project as reference panel
2,925,090 SNPs were included in meta-analysis
Stage 2: de novo replication in Chinese population
Meta-analysis of all Chinese cohorts in stage 1+2
b) Replication of 2 SNPs in Chinese families
a) Replication of 11 SNPs in Chinese case-control cohorts
Shanghai 1
(4,035 cases and 3,964 controls)
Hong Kong 2 in 178 families
(325 cases and 368 controls)
Shanghai 2 in 248 families
(657 cases and 168 controls)
Hong Kong 1
(5,366 cases and 2,474 controls)
Two SNPs: PAX4 rs10229583 and TRPS1 rs2737250
p< 4.5×10-3
Stage 4: in silico replication in non-East Asian populations
One SNP: PAX4 rs10229583
p<5×10-8
Stage 3: in silico replication in East Asian populations 
Japanese
(4,465 cases and 3,023 controls)
Singapore Chinese 1
(1,082 cases and 1,006 controls)
Korean 1
(1,042 cases and 2,943 controls)
Singapore Chinese 2
(928 cases and 939 controls)
Meta-analysis of all East Asian cohorts in stage 1+2+3
Singapore Indian
(977 cases and 1,169 controls)
Singapore Malaysian
(794 cases and 1,204 controls)
Caucasian (DIAGRAM+)
(8,130 cases and 38,987 controls)
Korean 2
(1,183 cases and 1,305 controls)
Chinese
(1,873 cases and 1,839 controls)
Fig. 1 Summary of study
design. CHB, Han Chinese in
Beijing, China; JPT, Japanese
in Tokyo, Japan
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applied to combine effect size (β±SE) from multiple groups
under the fixed effect model.
We performed bioinformatics and cis-expression quanti-
tative trait loci (eQTL) analysis for functional implication of
the identified SNP. See the ESM Methods for additional
information on methods, including adjustment for genomic
control and the gene network analysis.
Results
Meta-analysis of patients with Chinese ancestry A summa-
ry of the study design and the clinical characteristics of the
participants in all stages are shown in Fig. 1 and Table 1. In
stage 1, we genotyped 684 patients with type 2 diabetes and
955 controls. We did not detect any population stratification
between case and control individuals in multidimensional
scaling analysis for all GWAS (ESM Fig. 2). Meta-analysis
was implemented to combine the individual association re-
sults for 2,925,090 imputed and genotyped SNPs (under
additive genetic models) available in all three GWAS using
the inverse-variance approach for random effect models.
In the stage 1 meta-analysis of three Chinese GWAS, 44
SNPs within five loci were prioritised for follow-up (Fig. 2 and
ESM Table 5). We did not observe a substantial change in the
stage 1 results after adjusting either for λs (1.01–1.04 in
individual cohorts) or the first principal component in the
meta-analysis, reflecting that the results were not likely to be
due to population stratification (ESM Fig. 3 and ESMTable 6).
Of the five loci identified in stage 1, CDKN2A/B has
previously been reported to be strongly associated with type
2 diabetes. In line with our previous findings, two SNPs in
CDKN2A/B showing strong signals for type 2 diabetes in the
present study were in high LD (r2≈0.8) with rs10811661,
which is well-replicated in most populations. After eliminat-
ing the signal of CDKN2A/B and redundant markers, we took
forward 13 top and proxy SNPs among the remaining 42
SNPs in four regions to stage 2, de novo replication, in two
independent Chinese case–control cohorts (ESM Table 3). We
successfully obtained genotypes for 11 SNPs in Hong Kong
replication 1 cohort with 5,366 cases and 2,474 controls, and
Shanghai replication 1 cohort with 4,035 cases and 3,964
controls to proceed for subsequent analysis (ESM Table 4).
Of these, rs10229583 and rs2737250, located on chromo-
somes 7 and 8, respectively, gave p≤4.5×10−3 (threshold of
significance after Bonferroni correction) with the same direc-
tions of association as the original signals (Table 2). These two
SNPs were genotyped in 1,518 additional samples from 426
families of Han Chinese descent (325 cases and 368 controls
from 178HongKong families, and 657 cases and 168 controls
from 248 Shanghai families). Although we did not detect a
significant association in either family study using ALR, all
were in the concordant direction for rs10229583 (ESM
Table 7). Taken together, the overall observed association for
type 2 diabetes with rs10229583 by combining all studies
from Chinese ancestry in stages 1 and 2 yielded an OR (95%
CI) of 1.18 (1.11, 1.25) with a corresponding p=2.6×10−8
(Table 3). For another variant taken to genotyping in family
samples, rs2737250, meta-analysis of GWAS and de novo
genotyping in the Hong Kong and Shanghai case–control
samples revealed OR 1.10 (1.05, 1.15) with a corresponding
p=7.05×10−5 using a fixed effect model (p for heterogeneity
test=0.0012, I2=0.852), with OR 1.16 (1.01, 1.33), p=0.0299
by random effect model. However, genotyping of the variant
in the Hong Kong and Shanghai family samples suggested an
association in the opposite direction (ESM Table 7).
Meta-analysis in East Asian and other populations To fur-
ther validate the association of rs10229583 with type 2
diabetes, we conducted in silico replication of rs10229583
in five East Asian GWAS (one Japanese, two Korean, one
Singapore Chinese and one Han Chinese study), and three
non-East Asian GWAS (Singapore Indian, Singapore Malay-
sian and the DIAGRAM Consortium). Meta-analysis for the
East Asian populations (p=2.3×10−10) gave an OR (95% CI)
of 1.14 (1.09, 1.19). Among non-East Asian populations, we
observed replication of the association in participants of Euro-
pean descent from the DIAGRAMConsortium (p=8.6×10−3),
Fig. 2 Manhattan plot of combined genome-wide association results
from the Hong Kong 1, Hong Kong 2 and Shanghai studies based on
the random effect models. The y-axis represents the −log10 p value, and
the x-axis represents the 2,925,090 analysed SNPs. The dashed
horizontal line indicates the threshold of significance p<1×10−5. There
are 44 points with p<1×10−5, and the arrow and labels localise the
susceptibility loci to type 2 diabetes uncovered in the present study
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with OR 1.06 and (95% CI 1.02, 1.12) (Table 3 and Figs 3 and
4).
Impact of rs10229583 on clinical traits and course of
disease We next investigated the associations of rs10229583
with the AAD of type 2 diabetes and quantitative metabolic
traits related to type 2 diabetes. Among all the patients with
type 2 diabetes, individuals who carried the common, type 2
diabetes risk allele (G) were concordantly and significantly
younger at the time of diagnosis in both Hong Kong and
Shanghai, and the meta-analysis showed that presence of the
risk variant had a significant association with younger AAD
Fig. 3 Regional plots for the
identified variant rs10229583,
including results for both
genotyped and imputed SNPs in
the Chinese population. The
purple circle and diamond
represent the sentinel SNP in
meta-analysis of three GWAS in
the stage 1 and the East Asian
meta-analysis in stages 1 + 2 +
3, respectively. Other SNPs are
coloured according to their
level of LD, which is measured
by r2, with the sentinel SNP.
The recombination rates
estimated from the 1000
Genomes project JPT + CHB
data are shown. CHB, Han
Chinese in Beijing, China; JPT,
Japanese in Tokyo, Japan
0.0 1.0 2.0 3.0 4.0
OR (95% CI)
Hong Kong GWAS 1
Hong Kong replication 1
Shanghai replication 1






Singapore Chinese replication 1+2




Hong Kong GWAS 2
Shanghai GWAS
Meta-analysis of GWAS
OR (95% CI) 1.66 (1.33, 2.07)
p=7.7×10-6
OR (95% CI) 1.18 (1.11, 1.25)
p=2.6×10-8
OR (95% CI) 1.14 (1.09, 1.19) 
p=2.3×10-10
Chinese replication
Fig. 4 Forest plot for meta-
analysis of the association
between type 2 diabetes and
rs10229583 for all populations
in the present study. ORs and
95% CIs were reported with
respect to the type 2 diabetes-
related risk alleles (G)
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(p=2.3×10−4, βunadjusted±SE=−0.90±0.24), which remained
unchanged following adjustment for sex and BMI (ESM
Table 8). We also observed a nominal association of the
G-alleles of rs10229583 with beta cell function as assessed
by HOMA-B (βunadjusted±SE=−0.06±0.03, p=0.0221) in
healthy Hong Kong adolescents, a reduced Stumvoll Index
(βunadjusted±SE=0.03±0.01, p=0.0303) and increased fasting
plasma glucose (FPG) level (βunadjusted±SE=0.03±0.01,
p=0.0460) in healthy Shanghai adults (Fig. 5).
Functional implication of the identified locus rs10229583 In
order to evaluate the functional implication of our identified
variant, we performed an extensive bioinformatics analysis.
Consistent with its observed effect on pancreatic beta cell
function, the gene region of our locus has been identified as
one of the islet-selective clusters of open regulatory ele-
ments using a formaldehyde-assisted isolation of regulatory
elements coupled with high-throughput sequencing in hu-
man pancreatic islets [26]. In addition, the variant and its
tagging SNPs lie within an area near PAX4 and SND1, which
is enriched with DNase I hypersensitive sites, histone H3
lysine modifications and CCCTC factor binding in human
islets (ESM Fig. 4) [27].
We next investigated the relationship of rs10229583 with
eQTLs in adipose tissue and other tissues in available datasets.
The variant rs1440971, a proxy of our associated SNP
(MAF∼0.1, r2=0.8 and D'=1, to rs10229583), was signifi-
cantly associated with the level of expression ofGRM8, ARF5
and PAX4 in lymphoblastoid cells in the GenCord Project,
although this did not correlate with the eQTL peak (ESM
Fig. 5 and ESM Table 9) [28]. Analysis of all eQTLs associ-
ated with rs10229583, or its close proxy, rs1440971, was
performed using data from the Multiple Tissue Human Ex-
pression Resource (MuTHER) Consortium [29]. Of note,
eQTL data were only available for PAX4 in adipose tissue,
but not lymphoblastoid cell lines (LCLs) or skin, for which no
expression data were available from MuTHER. There was a
nominal association (p<0.05) between the variant and expres-
sion of C7orf54 and ARF5 in LCLs, and C7orf68 in adipose
tissue (ESM Table 10). The r2 between the GWAS SNP and
the peak eQTL SNPs ranged between 0.56 and 1.
Complex diseases such as type 2 diabetes are caused by a
combination of alterations, and each genomic perturbation
or alteration can potentially impact on thousands of genes
[30, 31]. Nevertheless, functionally important genes often
organise into the same pathway of functional grouping.
Therefore, we can overlay the alterations on a gene network
that was built using highly confident gene–gene relation-
ships (ESM Fig. 6) [32]. We identified interactions between
these genes, with additional interaction with other key pan-
creatic transcription factors such as NEUGRO3 (ESM
Fig. 6). Taken together, we speculate that ARF5, GCC1,
SND1 and PAX4 may function together with NEUGRO3 in
the same network for pancreatic islet development.
Heterogeneity of effect in Chinese vs other ethnic groups To
investigate why the novel loci identified in the present study
had not been detected in previous GWAS performed in other
populations, we examined the heterogeneity of effect be-
tween East Asians and Europeans. There was no evidence of
heterogeneity of effect between Chinese, Korean and Japa-
nese populations, but significant heterogeneity of effect was
seen between Han Chinese and individuals of European
descent in the DIAGRAM Consortium, as well as between
Chinese, Malaysians and Indians (ESM Table 11).
To test for the variation of LD structure between Chinese
and other populations, we implemented the targeted varLD
approach to examine the pattern of r2 between every pair of
SNPs within the 100 kb region centred on our index SNP
rs10229583. (www.statgen.nus.edu.sg/~SGVP/software/
varld.html) [33]. This region shows highly significant evi-
dence of LD variation between Chinese, European (Monte
Carlo [MC] p=0.0018), and African (MC p=0.0003) in-



























































Fig. 5 Associations of the risk variant (G allele) of rs10229583 with
measures of insulin secretion in Chinese controls. (a) Association with
reduced HOMA-B in a Hong Kong Chinese adolescent cohort
(p=0.0221). (b) Association with a reduced Stumvoll Index of beta
cell function in healthy Shanghai controls (p=0.0303). (c) Association
of the risk variant with higher FPG in healthy Shanghai controls
(p=0.0460). Data are expressed as mean (for FPG) or geometric mean
(for HOMA-B and Stumvoll Index). SDs or 95% CIs are expressed as
error bars. The number of individuals analysed for each genotype is
shown in parentheses under each column
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Chinese and Japanese (MC p=0.0107) (ESM Table 12 and
ESM Figs 7 and 8). We also observed discrepancies in allele
frequency of rs10229583 between East Asians, Europeans
and Africans (ESM Table 12).
Discussion
This study reports a meta-analysis of GWAS for type 2
diabetes in a Chinese population, and has identified a novel
diabetes-associated locus. Furthermore, we replicated the
association in additional East Asian samples, and found an
association in samples of European descent. In addition to
the multiethnic samples used in our study, our study also
benefits from a detailed phenotyping of the Chinese sam-
ples, which allowed additional analyses of the effect of the
risk variant on clinical traits and the course of disease to be
carried out.
Type 2 diabetes in Asians is characterised by an earlier
AAD, strong family history and evidence of impaired beta
cell function [2, 3]. In a recent nationwide study conducted
in China, the prevalence of diabetes was 3.2% among per-
sons aged 20–39 years, and 11.5% among adults aged 40–
59 [4]. The risk variant we identified, rs10229583, was
associated with earlier AAD in both the Hong Kong and
Shanghai samples, highlighting its potential contribution to
young-onset diabetes in the Chinese population. Healthy
adults and adolescents who carry the risk variant were found
to have elevated fasting glucose and impaired beta cell
function, respectively.
The novel locus for type 2 diabetes we identified,
rs10229583, is located downstream of the ARF5 and PAX4
genes in 7q32, and upstream of SND1. PAX4, which is a
member of the paired box family of transcription factors, plays
a critical role in pancreatic beta cell formation during fetal
development [34, 35] and is therefore a very strong candidate
for the implicated gene. The gene region lies within an area of
islet-specific cluster of open chromatin sites andmay therefore
act in cis with local chromatin and regulatory changes [25].
PAX4 is expressed in early pancreatic endocrine cells, but
expression is later restricted to beta cells and it is not expressed
in mature pancreas [36]. In pancreatic endocrine cells, PAX4
represses ghrelin and glucagon expression, and can induce the
expression of PDX1, a key transcription factor for islet devel-
opment [37]. Targeted disruption of PAX4 in mice was found
to lead to reduced beta cell mass at birth [37].
Several human studies have implicated PAX4 in the path-
ogenesis of diabetes [38, 39]. In one report, a missense
mutation (R121W) was identified in six heterozygous pa-
tients and one homozygous patient out of 200 unrelated
Japanese patients with type 2 diabetes [39]. For example,
Japanese patients carrying PAX4 mutations have severe de-
fects in first-phase insulin secretion [40]. Mutations in PAX4
may lead to rare monogenic forms of young-onset diabetes
[41]. Common variants in several other MODY genes,
namely, HNF4a, HNF1a and TCF2, have been identified
as susceptibility loci for type 2 diabetes [42].
Our finding is consistent with other studies that have
highlighted the important role of genes implicated in pan-
creatic development in the pathogenesis of type 2 diabetes.
In a previous study, a risk variant at HNF4a has been found
to be associated with increased risk of type 2 diabetes, and
carriers of the risk allele have impaired beta cell function
[43]. The MAF of the R121W PAX4 mutation was 1% in
Asians, and the mutation is in low LD with rs10229583. It is
possible that both rare mutations and common variation
within the same gene confer risk towards type 2 diabetes
independently. The common variant we identified,
rs10229583, may be associated with altered gene expres-
sion, while the other rare non-synonymous mutations lead to
impaired gene function. For example, while common non-
coding variants in MTNR1B increase type 2 diabetes risk
with a modest effect, large-scale resequencing has identified
rare loss-of-function MTNR1B variants that significantly
contribute towards type 2 diabetes risk [44]. Some regula-
tory elements harbouring type 2 diabetes-associated loci
have recently been found to exhibit allele-specific differ-
ences in activity, providing evidence supporting the func-
tional role of non-coding common variants identified
through GWAS [26, 27].
The recent East Asian meta-analysis comprising eight
type 2 diabetes GWAS identified a locus on chromosome
7 near GRIP and GCC1-PAX4 to be associated with type 2
diabetes. The protein encoded by GCC1 may play a role in
transmembrane transport [45]. The variant identified from
the East Asian study, rs6467136, appears to be independent
of our signal, with r2=0.044 in our Chinese samples (ESM
Fig. 8). Furthermore, we found no change in the effect size
of rs10229583 after conditioning on rs6467136 (OR [95%
CI]=1.20 [1.11, 1.29], p=4.6×10−6 vs OR [95% CI]=1.19
[1.10, 1.29), p=1.6×10−5, before and after the conditional
analysis in 9,886 Chinese samples). Likewise, rs6467136
had little change in effect after conditioning on rs10229583
(OR [95% CI]=1.09 [1.02, 1.17], p=0.0125 before; OR
[95% CI]=1.07 [0.99, 1.15], p=0.0729 after). In the recent
analysis from the DIAGRAM Consortium, rs231362 near
KCNQ1 was identified to be associated with type 2 diabetes.
This signal is independent of the original signal identified in
the Japanese population as revealed by conditional analysis.
Consistent with the evidence observed for KCNQ1, our
finding highlighted that multiple common genetic variations
within the same gene region may independently contribute
to disease risk [6, 12]. It will be worthwhile undertaking a
further investigation of this region to search for population-
specific and/or disease causal variants in different ethnic
groups by fine-mapping as well as transethnic mapping.
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The other genes in the region of our identified variant are
also potential candidate genes for diabetes. ARF5 belongs to
a family of guanine nucleotide-binding proteins that have
been shown to play a role in vesicular trafficking and as
activators of phospholipase D [46]. Islet expression of ARF5
was found to be induced threefold in rats receiving a high-
carbohydrate diet [47]. The nearby SND1 gene, also known
as the p100 transcription co-activator, is a member of the
micronuclease family and plays a key role in transcription
and splicing. The p100 transcriptional co-activator is present
in endocrine cells and tissues, including the pancreas of
cattle [48].
Among the type 2 diabetes loci first identified in non-
European populations, other than KCNQ1, few have consis-
tently been found to show a significant association in studies
of individuals of European descent [6, 14, 15, 42]. The
diabetes gene variant we identified, rs10229583, also
showed a significant association in Europeans in the DIA-
GRAM Consortium, with a smaller effect size compared
with East Asian individuals (p=0.0024 by Cochran’s Q
statistics, I2=0.8913). Interestingly, rare PAX4 mutations
were first identified in Asian MODY probands [39, 41],
but seldom found in those of European descent [49, 50].
This suggests that PAX4, like KCNQ1, may be particularly
relevant for the pathogenesis of type 2 diabetes in East
Asians individuals. Interestingly, rs10229583 is also in
strong LD with a region spanning the neighbouring SND1
gene (Fig. 3). Further resequencing and transethnic mapping
should help to identify the causal gene variant for type 2
diabetes within this region.
The novel locus we identified in Chinese individuals
with type 2 diabetes has not been detected in previous
GWAS performed in mainly individuals of European
descent. We noted a highly significant LD variation
between Chinese and European individuals in the region
surrounding our identified variant. There is also signif-
icant variation in allele frequencies in Chinese compared
with Europeans, as well as between Chinese and Afri-
can individuals. This ethnic difference in LD pattern
and risk allele frequency may lead to a differential
impact in different populations and warrants further
investigation by resequencing.
Our study has several limitations. The sample size of our
GWAS was modest, resulting in limited power to identify
genetic variants with small effect sizes. We have limited our
discovery study to Southern Han Chinese, although the
consistent replication seen in other East Asian population
suggests that the findings may be applicable to other
populations of Chinese descent.
In summary, we identify rs10229583 near PAX4 as a
novel locus for type 2 diabetes in Chinese and other
populations, providing new insights into the pathogenesis
of type 2 diabetes.
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